FAP and neoplasm: CAFs express high levels of fibroblast activation protein (FAP), and FAP-specific CAR T cells engineered to secrete ECM-degrading enzymes have been associated with improved CAR T cell function through inhibition of tumor stromagenesis, decrease of tumor vascular density and disrupting spatial orientation of tumor cells (24, 43).